KPRX News and Press, Kiora Pharmaceuticals Inc. From 04/21/23

Encinitas, California--(Newsfile Corp. - April 21, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed Mark Pennesi, M.D., Ph.D., the Kenneth C. Swan Endowed Professor in Ophthalmology and Molecular and Medical Genetics and the Chief of the Paul H. Casey Ophthalmic Genetics Division at the...

Encinitas, California--(Newsfile Corp. - April 17, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) enrolled the first patient in its Phase 2 trial of KIO-101 in the treatment of the Ocular Presentations of Rheumatoid Arthritis and other autoimmune diseases (OPRA+). This clinical trial is a phase 2, ...

Encinitas, California--(Newsfile Corp. - March 30, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced its late-breaking abstract detailing functional Magnetic Resonance Imaging (fMRI) results from the ABACUS Phase 1b study of KIO-301 in patients with retiniti...

2023-03-23 07:55:50 ET Kiora Pharmaceuticals press release ( NASDAQ: KPRX ): Q4 Net loss was $2.5 million for the fourth quarter of 2022, decrease of $3.7 million compared to the fourth quarter of 2021 of $6.2 million. Cash and cash equivalents were $6.0 million as of...

Encinitas, California--(Newsfile Corp. - March 23, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today is providing a business update and reporting financial results for the year ended December 31, 2022. CEO Commentary: "In 2022, we advanced our pipeline of...

Encinitas, California--(Newsfile Corp. - March 10, 2023) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") today announced three abstract acceptances for oral and poster presentation at the 2023 Association for Research in Vision and Ophthalmology (ARVO) meeting in New Orle...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: David Tonelson/Shutterstock.com Blink Charging (NASDAQ: BLNK ) stock is sliding lower on Tuesday following an update on its public offering plans . Blink Charging announced today that it intends to sell $...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Kiora Pharmaceuticals (NASDAQ: KPRX ) stock is heading higher on Tuesday thanks to an update on its KIO-101 eye drops. The big news here is the treatment getting investigational new drug app...

Penny Stock News and Investing: Staying Informed To Make Better Decisions Whether you’re trading penny stocks or high-priced names like Apple or Amazon, staying informed about the latest news and events helps. News provides valuable insights into market trends, economic conditions,...

Nano-cap stock Kiora Pharmaceuticals ( NASDAQ: KPRX ) added ~59% pre-market Tuesday after announcing regulatory clearance for its investigational new drug (IND) application targeted at eye disease candidate KIO-101. With the IND, the company has sought to start a Phase 2 trial for...